ENVALITH
ペットゴー株式会社 logo

Petgo Corporation

7140・Growth Market・Retail Trade

Official website
ペットゴー株式会社 logo
Petgo Corporation7140

Business

petgo Inc. is a pet healthcare-focused e-commerce company founded in 2004. It sells veterinary medicines, therapeutic diets, supplements, and other products through a multi-channel approach combining its proprietary EC site, multiple online malls, and offline channels. Since 2020, it has developed the DTC brand "Vets One (DTC brand)", and in FY2026 (ending March 2026), the DTC brand's share of sales reached 33.7%. In 2025, the company made the Pet Media Business (FLAFFY) a subsidiary, and in December 2025 made the dog daycare matching service (DogHuggy) a subsidiary, expanding its business domain from product consumption to experience consumption. It holds a customer base of 2.77 million cumulative unique purchasers and 460,000 active purchasers.

Business Model

The company acquires customers through sales of national brand products while improving gross margin by directing them toward Vets One (DTC brand), which is planned and manufactured (OEM) in-house. It maximizes sales opportunities through multi-channel deployment across its proprietary e-commerce site, Rakuten, Amazon, Yahoo, and others, and enhances customer LTV through subscription-based recurring purchases (subscription commerce). The recurring purchase ratio on the proprietary e-commerce site reached 56% (FY2026, ending March 2026), and the business maintains a stable revenue structure in which repeat customers account for approximately 80% of online sales.

Company Strengths

Through sales activities spanning its own e-commerce site, third-party e-commerce platforms, and offline channels, the company has accumulated 2.77 million cumulative unique purchasers and 460,000 active purchasers. It leverages high-value-added pet data—covering pet species, breeds, life stages, and diseases—for DTC brand product planning, marketing, and referrals to group companies, forming an information asset that competitors find difficult to replicate in a short period.

The subscription purchase ratio on the company's proprietary e-commerce site has risen continuously from 33% in the 17th fiscal period to 56% in the 22nd fiscal period. Approximately 80% of online sales come from repeat customers, and the combination of pet healthcare products' characteristics as daily consumables with high convenience has formed a stable revenue base.

Sales of the DTC brand "Vets One" (launched in April 2020) reached ¥2,493 million in FY2026 (ending March 2026), up 27.8% year on year, with its share of total brand sales expanding from 20.9% in the previous period to 33.7%. The company has been expanding its product lineup to include therapeutic diets, flea and tick control medications, and supplements, accumulating a track record of reducing dependence on national brand products and improving gross margins.

ENVALITH's Perspective

In FY2026 (ending March 2026), net sales fell to ¥7,420 million (down 17.8% year-on-year), marking a second consecutive year of substantial revenue decline, with the company falling into an operating loss of ¥204 million and a net loss attributable to owners of the parent of ¥270 million. The change in the distribution channel for Royal Canin Japon LLC's therapeutic diet food brand (disclosed in September 2024) directly hit National brand products sales, while advertising and promotional investment in the DTC brand kept SG&A expenses at an elevated level (¥2,478 million). The structure in which conversion costs from the DTC shift are squeezing profitability is clear, and the feasibility of a return to profitability in FY2027 (ending March 2027) (operating profit forecast of ¥153 million) needs to be carefully assessed.

The period-end balance of cash and cash equivalents fell sharply to ¥838 million (down ¥425 million from ¥1,264 million in the previous period). Investing cash flow (-¥372 million) was primarily due to the acquisitions of FLAFFY and DogHuggy (¥305 million in expenditure). Short-term borrowings of ¥825 million and long-term borrowings (including current portion) of ¥292 million mean interest-bearing debt remains at an elevated level, and the equity ratio declined to 32.0% (from 37.0% in the previous period). Operating cash flow was also negative at -¥47 million, and if the company cannot return to profitability in FY2027 (ending March 2027), there are concerns about a further deterioration in financial capacity.

As an external factor, the pet healthcare market is expected to expand over the medium to long term due to the lengthening average lifespan of pets and the increase in annual pet-related spending per animal. On the other hand, the number of dogs kept as pets is on a declining trend, making it difficult to expect a substantial increase in volume. Raising awareness of the DTC brand requires continuous advertising investment, and there is a risk that new entrants from competitors and intensifying price competition could hinder the recovery in profitability. Achieving the FY2027 (ending March 2027) forecast (net sales of ¥7,992 million, up 7.7% year-on-year) will require a further expansion of DTC brand sales.

Growth Strategy

"DTC Shift" aiming to achieve a high-profitability business structure through transformation toward a DTC brand-centered business model

Continued launch of new products including therapeutic diet foods, further expanding the DTC brand sales ratio from 33.7% (FY2026, ending March 2026). Aiming to improve the profit structure by increasing the composition ratio of high-gross-margin DTC products.

Expanding DTC brand deployment to offline stores such as home centers, while promoting new openings of DTC brand specialty stores on various online malls. Aiming to increase the DTC ratio in sales channels other than the company's own e-commerce site.

FLAFFY (Pet Media Business) was consolidated in April 2025, and DogHuggy (Pet Services) was consolidated in December 2025. The Pet Media Business recorded net sales of ¥291 million and operating profit of ¥57 million in FY2026 (ending March 2026), beginning to function as a new revenue source.

Disclosed company forecast for FY2027 (ending March 2027) of net sales of ¥7,992 million (up 7.7% year on year), operating profit of ¥153 million, ordinary profit of ¥138 million, and profit attributable to owners of parent of ¥82 million. Plans to recover from a loss through continuation of the DTC shift.

Last updated: July 19, 2026